Biotechnology
OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF
SINGAPORE, Nov. 17, 2021 /PRNewswire/ -- OncoOne
2021-11-17 09:10
3149
Recbio Receives Pharmaceutical Production License from Jiangsu Medical Products Administration for Production of COVID-19 Vaccine
TAIZHOU, China, Nov. 17, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. ("Recbio"), a biopharmaceutical company focusing on the research, development and commercialization of innovative vaccines that can address prevalent diseases with significant burdens, recently announced that the c...
2021-11-17 09:00
3151
Sofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental (beneath the chin) and Neck Facial Areas
The new indications include Eyebrow lifts and lifting of Lax tissue of the Submental and Neck Areas 80% of patients participating in a multi-site clinical trial saw improvement in just 12 weeks TUSTIN, Calif., Nov. 16, 2021 /PRNewswire/ -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in...
2021-11-16 23:23
3660
FibroBiologics Secures $100 Million Capital Commitment from GEM as Company Seeks to Go Public
The Company plans to go public via SPAC, reverse merger, or a direct listing HOUSTON, Nov. 16, 2021 /PRNewswire/ -- FibroBiologics, a clinical stage company developing fibroblast-based therapeutic cures for chronic diseases, announced today that it has signed an agreement with GEM Global Y...
2021-11-16 23:20
1854
Molecular Stethoscope, Inc. Announces Presentation of Primary Sclerosing Cholangitis (PSC) Study at the AASLD Liver Meeting 2021
Study results demonstrate the utility of the Company's Next-Generation cf-mRNA Liquid Biopsy Technology Platform for the characterization of PSC PALO ALTO, Calif., Nov. 16, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology company, announces presentation of its ...
2021-11-16 19:00
1518
R&D Milestone: HebaBiz Biotech's application for phase III clinical trial in China for Clevudine (L-FMAU), an anti-hepatitis B virus drug candidate under development has been approved
BEIJING, Nov. 15, 2021 /PRNewswire/ -- HebaBiz Biotech is pleased to announce that inNovember 2021, the Center for Drug Evaluation (CDE) of The National Medical Products Administration (NMPA) ofChina has approved the application for phase III clinical study of Clevudine (L-FMAU), a drug candidate...
2021-11-15 22:47
3285
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373
GAITHERSBURG, Md., Nov. 15, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK bioscience), a biotechnology company inSouth Korea, today...
2021-11-15 22:39
4381
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients
- Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care - Top-line results for Part A of the study, designed to evaluate safety and tolerability of RHB-107 and dose sel...
2021-11-15 20:00
4246
Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
SEOUL, South Korea, Nov. 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx), has announced the opening of an eighth global subsidiary, strategically located in Bogotá,Colombia. The new entity, known as 'Seegene Colombia S.A....
2021-11-15 19:00
2237
Vazyme goes public on Shanghai Stock Exchange today
NANJING, China, Nov. 15, 2021 /PRNewswire/ -- On November 15, 2021, Nanjing
Vazyme Biotech Co., Ltd. (Vazyme) went public on the STAR MARKET of the
Shanghai Stock Exchange under the stock code 688105.
2021-11-15 16:28
4906
Labcorp Opens New Integrated Laboratory, Strengthens Bioanalytical Services In Asia-Pacific
SINGAPORE, Nov. 15, 2021 /PRNewswire/ -- Labcorp
2021-11-15 16:00
4114
Antengene Presents Compelling Preclinical Data on Two Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting on November 12, 2021
-ATG-101, a novel PD-L1/4-1BB bispecific antibody, shows potent in vivo anti-tumor efficacy in checkpoint inhibitor resistant/relapsed models while mitigating liver toxicity risk, computational analysis adds support to dosing strategy -ATG-017, an ERK1/2 inhibitor, in vivo combination supports c...
2021-11-15 08:25
3620
Research into gut microbiome-autism link reveals new perspective in collaborative Austism CRC study
BRISBANE, Australia, Nov. 12, 2021 /PRNewswire/ -- Results published in Cell, led by Mater Research and TheUniversity of Queensland, show that dietary restriction drives microbiome diversity changes in autistic individuals. In the largest study in the field to date, researchers analysed s...
2021-11-12 11:15
2590
Recbio Announces Promising Preliminary Results From First-in-Human Study of a COVID-19 Vaccine Candidate With Novel Adjuvant BFA03
* Well tolerated and good safety profile, no SAE or TEAE leading to early discontinuation, no abnormal vital signs/laboratory testing results with clinical significance * 20μg ReCOV induced high titer of anti-SARS-CoV-2 neutralizing antibodies, with at least comparable level than published da...
2021-11-12 07:55
4105
Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics
SAN DIEGO and BENGALURU, India, Nov. 11, 2021 /PRNewswire/ -- Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry andin-vitro ADME Service offerings. Jubilant Biosys provides services for Turning Point Therapeutics Inc. for multiple small mo...
2021-11-11 21:33
3335
New EZZ genomic products attract strong Chinese interest at CIIE 2021
SYDNEY, Nov. 11, 2021 /PRNewswire/ -- From November 5 to 10, the 4th China International ImportExpo took place in Shanghai, with a focus on global high-tech companies. EZZ Life Science Holdings Limited (ASX: EZZ), a leading company in life sciences inAustralia, was invited to participate for the ...
2021-11-11 04:00
3178
Hill's Pet Nutrition Partners With Bond Pet Foods, Inc. To Develop A Craft Meat Protein Produced Through Precision Fermentation
New Agreement to Explore Sustainable Meat Protein to Provide Long-Term Options for Cat and Dog Nutrition TOPEKA, Kan. and BOULDER, Colo., Nov. 10, 2021 /PRNewswire/ -- Hill's Pet Nutrition, a global leader in biology-based pet nutrition, and Bond Pet Foods, Inc., the Boulder-based leader in crea...
2021-11-10 22:00
2361
Say Cheese: Sophie's BioNutrients co-creates with Ingredion to develop its first microalgae-based dairy-free cheese
SINGAPORE, Nov. 10, 2021 /PRNewswire/ -- Sophie's BioNutrients
2021-11-10 10:00
3535
One BioMed launches the cartridge-based Xceler8(TM) Nucleic Acid Extraction Platform, the next generation in workflow simplification
SINGAPORE, Nov. 10, 2021 /PRNewswire/ -- One BioMed, a company focused on advancing human health through innovation, announced today the launch of their Xceler8™ Platform for high-yield extraction and purification of nucleic acids from biological samples. Pre-filled with all the necessary reagent...
2021-11-10 08:00
2326
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S.
FDA Lifts Partial Clinical Hold on INNOVATE Phase 3 Segment PLYMOUTH MEETING, Pa., Nov. 9, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer and HPV-a...
2021-11-09 21:00
3521
Week's Top Stories
Most Reposted
Digital Identity Co. Modernizes Thailand Immigration Bureau Services with AWS
[Picked up by 316 media titles]
2026-05-28 15:06Asian Society of Cardiovascular Imaging and Philips sign MOU to strengthen imaging capabilities across Asia Pacific
[Picked up by 291 media titles]
2026-05-28 17:34
ASEAN Business Advisory Council (ASEAN-BAC) and AVPN Establish Regional Platform to Strengthen Corporate Social Investment and Cross-Sector Collaboration Across Southeast Asia
[Picked up by 290 media titles]
2026-05-28 10:06Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
[Picked up by 290 media titles]
2026-05-27 09:16
Patong Stay & Dine Package at Courtyard by Marriott Phuket, Patong Beach Resort
[Picked up by 285 media titles]
2026-05-28 14:10
Most Read
Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
2026-05-27 09:16
6972
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
2026-05-30 11:58
6895
NYSE Content Update: Hinge Health Shares Up 72% One Year from its IPO
2026-05-28 21:14
6787
